Discontinued — last reported Q1 '17

Investment Proceeds

Investing

Thermo Fisher Scientific Investment Proceeds remained flat by 0.0% to $391.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 11.6%, from $442.50M to $391.25M. Over 3 years (FY 2022 to FY 2025), Investment Proceeds shows an upward trend with a 138.1% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2007
Last reportedQ1 2017

How to read this metric

An increase indicates the company is liquidating its investment portfolio, potentially to fund large capital projects, acquisitions, or dividends.

Detailed definition

The cash received from the sale or maturity of investment securities, including government bonds and corporate debt. Thi...

Peer comparison

This metric is often analyzed alongside 'Purchases of Investments' to determine the net movement in a company's 'cash pile'.

Metric ID: cf_proceeds_from_investments

Historical Data

4 years
 FY'22FY'23FY'24FY'25
Value$116.00M$15.00M$1.77B$1.57B
YoY Change—-87.1%>999%-11.6%
Range$15.00M – $1.77B
CAGR+138.1%
Avg YoY Growth>999%
Median YoY Growth-11.6%

Frequently Asked Questions

What is Thermo Fisher Scientific's investment proceeds?
Thermo Fisher Scientific (TMO) reported investment proceeds of $391.25M in Q4 2025.
How has Thermo Fisher Scientific's investment proceeds changed year-over-year?
Thermo Fisher Scientific's investment proceeds decreased by 11.6% year-over-year, from $442.50M to $391.25M.
What is the long-term trend for Thermo Fisher Scientific's investment proceeds?
Over 3 years (2022 to 2025), Thermo Fisher Scientific's investment proceeds has grown at a 138.1% compound annual growth rate (CAGR), from $116.00M to $1.57B.
What does investment proceeds mean?
Cash the company received when its investments matured or were sold.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.